

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.24855754 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.22289844 |
| 3 | vocalization behavior (GO:0071625) | 5.00673810 |
| 4 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.92550225 |
| 5 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.71719301 |
| 6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.68395440 |
| 7 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.62212571 |
| 8 | glutamate receptor signaling pathway (GO:0007215) | 4.60832297 |
| 9 | locomotory exploration behavior (GO:0035641) | 4.49658039 |
| 10 | protein localization to synapse (GO:0035418) | 4.47908217 |
| 11 | axonemal dynein complex assembly (GO:0070286) | 4.45762417 |
| 12 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.40492835 |
| 13 | epithelial cilium movement (GO:0003351) | 4.37781009 |
| 14 | synaptic vesicle exocytosis (GO:0016079) | 4.32192591 |
| 15 | neuronal action potential propagation (GO:0019227) | 4.30177381 |
| 16 | cilium movement (GO:0003341) | 4.27591140 |
| 17 | neuron cell-cell adhesion (GO:0007158) | 4.25220904 |
| 18 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.09196957 |
| 19 | synaptic transmission, glutamatergic (GO:0035249) | 4.01190697 |
| 20 | neuron-neuron synaptic transmission (GO:0007270) | 3.99843218 |
| 21 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.98164623 |
| 22 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.96267821 |
| 23 | dendritic spine morphogenesis (GO:0060997) | 3.93432479 |
| 24 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.93289107 |
| 25 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.91828854 |
| 26 | synaptic vesicle maturation (GO:0016188) | 3.91756125 |
| 27 | glutamate secretion (GO:0014047) | 3.87855431 |
| 28 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.85420562 |
| 29 | exploration behavior (GO:0035640) | 3.83617609 |
| 30 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.82647663 |
| 31 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.80972017 |
| 32 | regulation of postsynaptic membrane potential (GO:0060078) | 3.70791847 |
| 33 | presynaptic membrane assembly (GO:0097105) | 3.70279809 |
| 34 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.68593131 |
| 35 | behavioral response to nicotine (GO:0035095) | 3.67621815 |
| 36 | regulation of synapse structural plasticity (GO:0051823) | 3.62356127 |
| 37 | neuron recognition (GO:0008038) | 3.59799115 |
| 38 | long-term memory (GO:0007616) | 3.59690220 |
| 39 | regulation of dendritic spine development (GO:0060998) | 3.58265813 |
| 40 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.57778588 |
| 41 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.55936401 |
| 42 | positive regulation of membrane potential (GO:0045838) | 3.55907017 |
| 43 | transmission of nerve impulse (GO:0019226) | 3.55368230 |
| 44 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.54008818 |
| 45 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.50939144 |
| 46 | presynaptic membrane organization (GO:0097090) | 3.47852499 |
| 47 | regulation of synaptic plasticity (GO:0048167) | 3.47291614 |
| 48 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.46107902 |
| 49 | postsynaptic membrane organization (GO:0001941) | 3.45750215 |
| 50 | regulation of synaptic vesicle transport (GO:1902803) | 3.41243871 |
| 51 | synaptic transmission, dopaminergic (GO:0001963) | 3.38697377 |
| 52 | long-term synaptic potentiation (GO:0060291) | 3.36626886 |
| 53 | axonal fasciculation (GO:0007413) | 3.36580615 |
| 54 | behavioral defense response (GO:0002209) | 3.36127769 |
| 55 | behavioral fear response (GO:0001662) | 3.36127769 |
| 56 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.36086835 |
| 57 | dendritic spine organization (GO:0097061) | 3.35262918 |
| 58 | response to histamine (GO:0034776) | 3.35174650 |
| 59 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.34870981 |
| 60 | neurotransmitter secretion (GO:0007269) | 3.33758908 |
| 61 | auditory behavior (GO:0031223) | 3.33453979 |
| 62 | regulation of glutamate secretion (GO:0014048) | 3.31823214 |
| 63 | positive regulation of dendritic spine development (GO:0060999) | 3.29360641 |
| 64 | positive regulation of neurotransmitter transport (GO:0051590) | 3.28002189 |
| 65 | regulation of cilium movement (GO:0003352) | 3.26116216 |
| 66 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.24309217 |
| 67 | response to amphetamine (GO:0001975) | 3.24162385 |
| 68 | lateral sprouting from an epithelium (GO:0060601) | 3.23358562 |
| 69 | axoneme assembly (GO:0035082) | 3.21140022 |
| 70 | layer formation in cerebral cortex (GO:0021819) | 3.20976569 |
| 71 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.20954411 |
| 72 | regulation of vesicle fusion (GO:0031338) | 3.20310693 |
| 73 | chemosensory behavior (GO:0007635) | 3.19073571 |
| 74 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.18074294 |
| 75 | fear response (GO:0042596) | 3.16141061 |
| 76 | learning (GO:0007612) | 3.15561996 |
| 77 | behavioral response to cocaine (GO:0048148) | 3.15513267 |
| 78 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.15076328 |
| 79 | nonmotile primary cilium assembly (GO:0035058) | 3.13024206 |
| 80 | prepulse inhibition (GO:0060134) | 3.04931023 |
| 81 | membrane depolarization (GO:0051899) | 3.01725114 |
| 82 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.98685572 |
| 83 | regulation of neurotransmitter secretion (GO:0046928) | 2.97565565 |
| 84 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.94223226 |
| 85 | response to auditory stimulus (GO:0010996) | 2.93742993 |
| 86 | central nervous system myelination (GO:0022010) | 2.93550872 |
| 87 | axon ensheathment in central nervous system (GO:0032291) | 2.93550872 |
| 88 | cellular potassium ion homeostasis (GO:0030007) | 2.92901007 |
| 89 | mechanosensory behavior (GO:0007638) | 2.92140688 |
| 90 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.91473237 |
| 91 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.91365820 |
| 92 | retinal ganglion cell axon guidance (GO:0031290) | 2.90627402 |
| 93 | detection of calcium ion (GO:0005513) | 2.90479196 |
| 94 | synapse assembly (GO:0007416) | 2.86141773 |
| 95 | startle response (GO:0001964) | 2.85445522 |
| 96 | neuronal ion channel clustering (GO:0045161) | 2.85424445 |
| 97 | neurotransmitter transport (GO:0006836) | 2.84696273 |
| 98 | gamma-aminobutyric acid transport (GO:0015812) | 2.83793601 |
| 99 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.82970159 |
| 100 | regulation of neurotransmitter transport (GO:0051588) | 2.82260266 |
| 101 | limb bud formation (GO:0060174) | 2.80806134 |
| 102 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.80346440 |
| 103 | ephrin receptor signaling pathway (GO:0048013) | 2.79987549 |
| 104 | long term synaptic depression (GO:0060292) | 2.79057777 |
| 105 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.78939391 |
| 106 | negative regulation of dendrite development (GO:2000171) | 2.78843016 |
| 107 | positive regulation of synapse maturation (GO:0090129) | 2.77655679 |
| 108 | synaptic vesicle endocytosis (GO:0048488) | 2.76318374 |
| 109 | regulation of female receptivity (GO:0045924) | 2.75500339 |
| 110 | regulation of synaptic transmission (GO:0050804) | 2.75110228 |
| 111 | neuromuscular process controlling balance (GO:0050885) | 2.74604218 |
| 112 | response to pheromone (GO:0019236) | 2.74094774 |
| 113 | positive regulation of synapse assembly (GO:0051965) | 2.73655358 |
| 114 | cochlea development (GO:0090102) | 2.73294329 |
| 115 | negative regulation of amino acid transport (GO:0051956) | 2.73027035 |
| 116 | cilium organization (GO:0044782) | 2.72831530 |
| 117 | associative learning (GO:0008306) | 2.72800581 |
| 118 | membrane hyperpolarization (GO:0060081) | 2.69894808 |
| 119 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.69578560 |
| 120 | cilium assembly (GO:0042384) | 2.68484549 |
| 121 | protein localization to cilium (GO:0061512) | 2.67674949 |
| 122 | cilium morphogenesis (GO:0060271) | 2.66791569 |
| 123 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.66223266 |
| 124 | intraciliary transport (GO:0042073) | 2.65555162 |
| 125 | proline transport (GO:0015824) | 2.65045431 |
| 126 | kidney morphogenesis (GO:0060993) | 2.64997312 |
| 127 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.64272168 |
| 128 | inner ear receptor stereocilium organization (GO:0060122) | 2.63198037 |
| 129 | serotonin metabolic process (GO:0042428) | 2.63105725 |
| 130 | primary amino compound metabolic process (GO:1901160) | 2.62266254 |
| 131 | motile cilium assembly (GO:0044458) | 2.61896755 |
| 132 | regulation of microtubule-based movement (GO:0060632) | 2.61314286 |
| 133 | left/right pattern formation (GO:0060972) | 2.58465401 |
| 134 | cerebellar granule cell differentiation (GO:0021707) | 2.55081973 |
| 135 | neuromuscular synaptic transmission (GO:0007274) | 2.54573151 |
| 136 | C4-dicarboxylate transport (GO:0015740) | 2.53150561 |
| 137 | retinal cone cell development (GO:0046549) | 2.53024302 |
| 138 | apical protein localization (GO:0045176) | 2.50436770 |
| 139 | positive regulation of meiosis (GO:0045836) | 2.46959431 |
| 140 | membrane depolarization during action potential (GO:0086010) | 2.46657725 |
| 141 | microtubule bundle formation (GO:0001578) | 2.44164884 |
| 142 | regulation of respiratory system process (GO:0044065) | 2.43801924 |
| 143 | cornea development in camera-type eye (GO:0061303) | 2.43632865 |
| 144 | establishment of planar polarity (GO:0001736) | 2.42718183 |
| 145 | establishment of tissue polarity (GO:0007164) | 2.42718183 |
| 146 | urinary tract smooth muscle contraction (GO:0014848) | 2.41989803 |
| 147 | protein polyglutamylation (GO:0018095) | 2.40341820 |
| 148 | nucleobase catabolic process (GO:0046113) | 2.40099119 |
| 149 | retina layer formation (GO:0010842) | 2.38177102 |
| 150 | short-term memory (GO:0007614) | 2.37192233 |
| 151 | behavioral response to ethanol (GO:0048149) | 2.36898864 |
| 152 | positive regulation of vesicle fusion (GO:0031340) | 2.36823194 |
| 153 | regulation of action potential (GO:0098900) | 2.35002608 |
| 154 | positive regulation of meiotic cell cycle (GO:0051446) | 2.33155492 |
| 155 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.30162437 |
| 156 | negative regulation of appetite (GO:0032099) | 2.29079075 |
| 157 | negative regulation of response to food (GO:0032096) | 2.29079075 |
| 158 | left/right axis specification (GO:0070986) | 2.27758638 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.61653522 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.65108808 |
| 3 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.39932537 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.21657702 |
| 5 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.18736928 |
| 6 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.87020586 |
| 7 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.87020586 |
| 8 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.83698709 |
| 9 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.77803778 |
| 10 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.74610379 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.73843059 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.71854429 |
| 13 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.62331652 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.51056910 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.38097157 |
| 16 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.35158439 |
| 17 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.32886500 |
| 18 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.31284198 |
| 19 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.21989855 |
| 20 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.20525935 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.10987057 |
| 22 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.09151085 |
| 23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.08350390 |
| 24 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.05479460 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.00694214 |
| 26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.83473680 |
| 27 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.81607150 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.80748119 |
| 29 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.72340222 |
| 30 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.70327468 |
| 31 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.68058971 |
| 32 | P300_19829295_ChIP-Seq_ESCs_Human | 1.65955063 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.62648804 |
| 34 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.60928219 |
| 35 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.60826454 |
| 36 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.58337440 |
| 37 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.57501719 |
| 38 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.56933471 |
| 39 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.55145734 |
| 40 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.51431773 |
| 41 | FUS_26573619_Chip-Seq_HEK293_Human | 1.46850325 |
| 42 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.43920039 |
| 43 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.42884240 |
| 44 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.40222365 |
| 45 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.39695662 |
| 46 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.39547986 |
| 47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.38881808 |
| 48 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.38262574 |
| 49 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.37246609 |
| 50 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.35706121 |
| 51 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.33290905 |
| 52 | * TP53_16413492_ChIP-PET_HCT116_Human | 1.32440110 |
| 53 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.31628033 |
| 54 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.30861727 |
| 55 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.30849041 |
| 56 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.30142267 |
| 57 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.28753750 |
| 58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27514566 |
| 59 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.25917299 |
| 60 | VDR_22108803_ChIP-Seq_LS180_Human | 1.25273897 |
| 61 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24547662 |
| 62 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.22597659 |
| 63 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22228213 |
| 64 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.20178091 |
| 65 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.20039592 |
| 66 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.18704958 |
| 67 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.18682478 |
| 68 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.17789504 |
| 69 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17275630 |
| 70 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.16003329 |
| 71 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.15041047 |
| 72 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14868275 |
| 73 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13311440 |
| 74 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.12755256 |
| 75 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11816619 |
| 76 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.11662123 |
| 77 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.11549524 |
| 78 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.11440115 |
| 79 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11157247 |
| 80 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.10521416 |
| 81 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10134517 |
| 82 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10001644 |
| 83 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.08747075 |
| 84 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.08564358 |
| 85 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.07455746 |
| 86 | RXR_22108803_ChIP-Seq_LS180_Human | 1.07312380 |
| 87 | STAT3_23295773_ChIP-Seq_U87_Human | 1.06814036 |
| 88 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.06237996 |
| 89 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.06144566 |
| 90 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.06137082 |
| 91 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.04672495 |
| 92 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.04066270 |
| 93 | * AR_19668381_ChIP-Seq_PC3_Human | 1.03258343 |
| 94 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.02814784 |
| 95 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01815796 |
| 96 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.01622892 |
| 97 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.01518414 |
| 98 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.01071200 |
| 99 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.00725515 |
| 100 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.00667805 |
| 101 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.99958120 |
| 102 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.99958120 |
| 103 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.99632991 |
| 104 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.99314116 |
| 105 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98663173 |
| 106 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.98632446 |
| 107 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.98252459 |
| 108 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98054237 |
| 109 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.98054237 |
| 110 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.97002715 |
| 111 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.96969462 |
| 112 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.95368143 |
| 113 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95355943 |
| 114 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.94796504 |
| 115 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.94212304 |
| 116 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93620098 |
| 117 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.93339109 |
| 118 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91955308 |
| 119 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.89147532 |
| 120 | EWS_26573619_Chip-Seq_HEK293_Human | 0.86409658 |
| 121 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.86254166 |
| 122 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86162714 |
| 123 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.86140792 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.20722302 |
| 2 | MP0003880_abnormal_central_pattern | 5.23274365 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.97188311 |
| 4 | MP0009745_abnormal_behavioral_response | 3.44665199 |
| 5 | MP0002063_abnormal_learning/memory/cond | 3.20610809 |
| 6 | MP0004270_analgesia | 3.15410039 |
| 7 | MP0001968_abnormal_touch/_nociception | 2.87471967 |
| 8 | MP0002822_catalepsy | 2.86547960 |
| 9 | MP0002064_seizures | 2.83816624 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.68505824 |
| 11 | MP0001486_abnormal_startle_reflex | 2.65890016 |
| 12 | MP0009046_muscle_twitch | 2.53933294 |
| 13 | MP0000579_abnormal_nail_morphology | 2.46883747 |
| 14 | MP0002272_abnormal_nervous_system | 2.45768762 |
| 15 | MP0002736_abnormal_nociception_after | 2.29168114 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.22768311 |
| 17 | MP0005423_abnormal_somatic_nervous | 2.21516035 |
| 18 | MP0001188_hyperpigmentation | 2.17791988 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 2.02800059 |
| 20 | MP0001440_abnormal_grooming_behavior | 1.97309552 |
| 21 | MP0005409_darkened_coat_color | 1.96586505 |
| 22 | MP0002735_abnormal_chemical_nociception | 1.96187258 |
| 23 | MP0001984_abnormal_olfaction | 1.84032164 |
| 24 | MP0008569_lethality_at_weaning | 1.76175936 |
| 25 | MP0002067_abnormal_sensory_capabilities | 1.75182266 |
| 26 | MP0000778_abnormal_nervous_system | 1.74141825 |
| 27 | MP0008875_abnormal_xenobiotic_pharmacok | 1.68327537 |
| 28 | MP0002557_abnormal_social/conspecific_i | 1.68159011 |
| 29 | MP0001970_abnormal_pain_threshold | 1.64758244 |
| 30 | MP0002184_abnormal_innervation | 1.64438898 |
| 31 | MP0002638_abnormal_pupillary_reflex | 1.64257404 |
| 32 | MP0002733_abnormal_thermal_nociception | 1.60159957 |
| 33 | MP0000569_abnormal_digit_pigmentation | 1.59876871 |
| 34 | MP0001529_abnormal_vocalization | 1.57675370 |
| 35 | MP0004133_heterotaxia | 1.54141539 |
| 36 | MP0005646_abnormal_pituitary_gland | 1.51636762 |
| 37 | MP0003283_abnormal_digestive_organ | 1.50592109 |
| 38 | MP0000427_abnormal_hair_cycle | 1.46902111 |
| 39 | MP0001905_abnormal_dopamine_level | 1.44875496 |
| 40 | MP0002909_abnormal_adrenal_gland | 1.41681985 |
| 41 | MP0005386_behavior/neurological_phenoty | 1.36622956 |
| 42 | MP0004924_abnormal_behavior | 1.36622956 |
| 43 | MP0009379_abnormal_foot_pigmentation | 1.35958137 |
| 44 | MP0004885_abnormal_endolymph | 1.35748480 |
| 45 | MP0004811_abnormal_neuron_physiology | 1.34870893 |
| 46 | MP0003787_abnormal_imprinting | 1.33637816 |
| 47 | MP0006072_abnormal_retinal_apoptosis | 1.31638038 |
| 48 | MP0002882_abnormal_neuron_morphology | 1.27271168 |
| 49 | MP0000955_abnormal_spinal_cord | 1.27264322 |
| 50 | MP0010030_abnormal_orbit_morphology | 1.26463825 |
| 51 | MP0005499_abnormal_olfactory_system | 1.25304807 |
| 52 | MP0005394_taste/olfaction_phenotype | 1.25304807 |
| 53 | MP0002653_abnormal_ependyma_morphology | 1.19050835 |
| 54 | MP0002066_abnormal_motor_capabilities/c | 1.16876909 |
| 55 | MP0006276_abnormal_autonomic_nervous | 1.16764181 |
| 56 | MP0004381_abnormal_hair_follicle | 1.16129832 |
| 57 | MP0002938_white_spotting | 1.15569691 |
| 58 | MP0005253_abnormal_eye_physiology | 1.14445946 |
| 59 | MP0004742_abnormal_vestibular_system | 1.13105249 |
| 60 | MP0009780_abnormal_chondrocyte_physiolo | 1.11908113 |
| 61 | MP0003937_abnormal_limbs/digits/tail_de | 1.10512420 |
| 62 | MP0003011_delayed_dark_adaptation | 1.09651900 |
| 63 | MP0003633_abnormal_nervous_system | 1.08513338 |
| 64 | MP0004043_abnormal_pH_regulation | 1.07882706 |
| 65 | MP0006292_abnormal_olfactory_placode | 1.07819237 |
| 66 | MP0003136_yellow_coat_color | 1.07756416 |
| 67 | MP0003879_abnormal_hair_cell | 1.05911850 |
| 68 | MP0005377_hearing/vestibular/ear_phenot | 1.05584692 |
| 69 | MP0003878_abnormal_ear_physiology | 1.05584692 |
| 70 | MP0003329_amyloid_beta_deposits | 1.03633604 |
| 71 | MP0010234_abnormal_vibrissa_follicle | 1.03430712 |
| 72 | MP0002282_abnormal_trachea_morphology | 1.03297573 |
| 73 | MP0002233_abnormal_nose_morphology | 1.02752865 |
| 74 | MP0004145_abnormal_muscle_electrophysio | 1.01371181 |
| 75 | MP0002160_abnormal_reproductive_system | 1.01245305 |
| 76 | MP0009053_abnormal_anal_canal | 0.99721110 |
| 77 | MP0008877_abnormal_DNA_methylation | 0.98552430 |
| 78 | MP0010678_abnormal_skin_adnexa | 0.97542351 |
| 79 | MP0000049_abnormal_middle_ear | 0.96011388 |
| 80 | MP0002234_abnormal_pharynx_morphology | 0.95725934 |
| 81 | MP0000383_abnormal_hair_follicle | 0.95468988 |
| 82 | MP0001502_abnormal_circadian_rhythm | 0.95229326 |
| 83 | MP0004484_altered_response_of | 0.94855621 |
| 84 | MP0003938_abnormal_ear_development | 0.94503095 |
| 85 | MP0004142_abnormal_muscle_tone | 0.94291028 |
| 86 | MP0008874_decreased_physiological_sensi | 0.94228922 |
| 87 | MP0003631_nervous_system_phenotype | 0.94184468 |
| 88 | MP0004858_abnormal_nervous_system | 0.94123937 |
| 89 | MP0003890_abnormal_embryonic-extraembry | 0.92520935 |
| 90 | MP0002152_abnormal_brain_morphology | 0.91356552 |
| 91 | MP0000631_abnormal_neuroendocrine_gland | 0.91079981 |
| 92 | MP0001177_atelectasis | 0.90704683 |
| 93 | MP0002796_impaired_skin_barrier | 0.90530680 |
| 94 | MP0002098_abnormal_vibrissa_morphology | 0.90028633 |
| 95 | MP0004085_abnormal_heartbeat | 0.89538718 |
| 96 | MP0002102_abnormal_ear_morphology | 0.88537380 |
| 97 | MP0005551_abnormal_eye_electrophysiolog | 0.85795162 |
| 98 | MP0003122_maternal_imprinting | 0.84649747 |
| 99 | MP0001346_abnormal_lacrimal_gland | 0.82733534 |
| 100 | MP0001963_abnormal_hearing_physiology | 0.82575276 |
| 101 | MP0008789_abnormal_olfactory_epithelium | 0.81880053 |
| 102 | MP0003755_abnormal_palate_morphology | 0.81628840 |
| 103 | MP0003861_abnormal_nervous_system | 0.80324684 |
| 104 | MP0010386_abnormal_urinary_bladder | 0.80299637 |
| 105 | MP0005195_abnormal_posterior_eye | 0.79996249 |
| 106 | MP0005645_abnormal_hypothalamus_physiol | 0.79259556 |
| 107 | MP0002752_abnormal_somatic_nervous | 0.78323375 |
| 108 | MP0003119_abnormal_digestive_system | 0.78283323 |
| 109 | MP0008872_abnormal_physiological_respon | 0.77010830 |
| 110 | MP0001485_abnormal_pinna_reflex | 0.76864761 |
| 111 | MP0000920_abnormal_myelination | 0.76074716 |
| 112 | MP0002069_abnormal_eating/drinking_beha | 0.75644955 |
| 113 | MP0005187_abnormal_penis_morphology | 0.75589994 |
| 114 | MP0001664_abnormal_digestion | 0.74786081 |
| 115 | MP0002876_abnormal_thyroid_physiology | 0.73225530 |
| 116 | MP0000026_abnormal_inner_ear | 0.73145678 |
| 117 | MP0003137_abnormal_impulse_conducting | 0.68891059 |
| 118 | MP0004215_abnormal_myocardial_fiber | 0.68729300 |
| 119 | MP0002249_abnormal_larynx_morphology | 0.68559853 |
| 120 | MP0002229_neurodegeneration | 0.68489823 |
| 121 | MP0005623_abnormal_meninges_morphology | 0.68267159 |
| 122 | MP0005174_abnormal_tail_pigmentation | 0.66084778 |
| 123 | MP0000751_myopathy | 0.65415729 |
| 124 | MP0003632_abnormal_nervous_system | 0.64289322 |
| 125 | MP0004510_myositis | 0.63927771 |
| 126 | MP0000647_abnormal_sebaceous_gland | 0.63875941 |
| 127 | MP0010771_integument_phenotype | 0.62608547 |
| 128 | MP0000762_abnormal_tongue_morphology | 0.62423408 |
| 129 | MP0002254_reproductive_system_inflammat | 0.62009592 |
| 130 | MP0000566_synostosis | 0.60581678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.43140743 |
| 2 | Myokymia (HP:0002411) | 5.81862127 |
| 3 | Focal seizures (HP:0007359) | 5.19517303 |
| 4 | Epileptic encephalopathy (HP:0200134) | 4.65078631 |
| 5 | Visual hallucinations (HP:0002367) | 4.64337749 |
| 6 | Broad-based gait (HP:0002136) | 4.34424887 |
| 7 | Febrile seizures (HP:0002373) | 4.28183935 |
| 8 | Atonic seizures (HP:0010819) | 4.01515064 |
| 9 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.95944919 |
| 10 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.72668288 |
| 11 | Absence seizures (HP:0002121) | 3.71445271 |
| 12 | Progressive cerebellar ataxia (HP:0002073) | 3.59402744 |
| 13 | True hermaphroditism (HP:0010459) | 3.52838319 |
| 14 | Pancreatic fibrosis (HP:0100732) | 3.50865445 |
| 15 | Hyperventilation (HP:0002883) | 3.48080291 |
| 16 | Pancreatic cysts (HP:0001737) | 3.45559019 |
| 17 | Dialeptic seizures (HP:0011146) | 3.44374925 |
| 18 | Abnormality of midbrain morphology (HP:0002418) | 3.43648100 |
| 19 | Molar tooth sign on MRI (HP:0002419) | 3.43648100 |
| 20 | Gaze-evoked nystagmus (HP:0000640) | 3.34291580 |
| 21 | Dysdiadochokinesis (HP:0002075) | 3.30586685 |
| 22 | Generalized tonic-clonic seizures (HP:0002069) | 3.29244596 |
| 23 | Rhinitis (HP:0012384) | 3.23518557 |
| 24 | Nephronophthisis (HP:0000090) | 3.04009145 |
| 25 | Amblyopia (HP:0000646) | 2.93018870 |
| 26 | Dysmetria (HP:0001310) | 2.89118282 |
| 27 | Medial flaring of the eyebrow (HP:0010747) | 2.82267025 |
| 28 | Obstructive sleep apnea (HP:0002870) | 2.81869688 |
| 29 | Poor eye contact (HP:0000817) | 2.78342133 |
| 30 | Truncal ataxia (HP:0002078) | 2.76566380 |
| 31 | Action tremor (HP:0002345) | 2.74223791 |
| 32 | Stereotypic behavior (HP:0000733) | 2.71340269 |
| 33 | Cystic liver disease (HP:0006706) | 2.70393193 |
| 34 | Gait imbalance (HP:0002141) | 2.67002549 |
| 35 | Anxiety (HP:0000739) | 2.66693348 |
| 36 | Split foot (HP:0001839) | 2.65112042 |
| 37 | Abnormality of the renal medulla (HP:0100957) | 2.64436218 |
| 38 | Absent/shortened dynein arms (HP:0200106) | 2.62176876 |
| 39 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.62176876 |
| 40 | Annular pancreas (HP:0001734) | 2.57476331 |
| 41 | Supranuclear gaze palsy (HP:0000605) | 2.49972252 |
| 42 | Genetic anticipation (HP:0003743) | 2.49546501 |
| 43 | Excessive salivation (HP:0003781) | 2.45948832 |
| 44 | Drooling (HP:0002307) | 2.45948832 |
| 45 | Postural instability (HP:0002172) | 2.45467023 |
| 46 | Depression (HP:0000716) | 2.43579845 |
| 47 | Congenital primary aphakia (HP:0007707) | 2.39896848 |
| 48 | Absent speech (HP:0001344) | 2.39620224 |
| 49 | Scanning speech (HP:0002168) | 2.34158032 |
| 50 | Neurofibrillary tangles (HP:0002185) | 2.34077651 |
| 51 | Progressive inability to walk (HP:0002505) | 2.29750672 |
| 52 | Cerebral inclusion bodies (HP:0100314) | 2.29349090 |
| 53 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.28155283 |
| 54 | Tubular atrophy (HP:0000092) | 2.27954728 |
| 55 | Impaired smooth pursuit (HP:0007772) | 2.27169558 |
| 56 | Chronic bronchitis (HP:0004469) | 2.24509363 |
| 57 | Fragile nails (HP:0001808) | 2.24485344 |
| 58 | Abnormal eating behavior (HP:0100738) | 2.23594838 |
| 59 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.23243119 |
| 60 | Impaired social interactions (HP:0000735) | 2.23148696 |
| 61 | Abnormal social behavior (HP:0012433) | 2.23148696 |
| 62 | Hemiparesis (HP:0001269) | 2.22458110 |
| 63 | Concave nail (HP:0001598) | 2.18601058 |
| 64 | Aplasia involving bones of the extremities (HP:0009825) | 2.17798367 |
| 65 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.17798367 |
| 66 | Aplasia of the phalanges of the hand (HP:0009802) | 2.17798367 |
| 67 | Abnormal drinking behavior (HP:0030082) | 2.15483656 |
| 68 | Polydipsia (HP:0001959) | 2.15483656 |
| 69 | Inability to walk (HP:0002540) | 2.14270987 |
| 70 | Nephrogenic diabetes insipidus (HP:0009806) | 2.14143437 |
| 71 | Lower limb amyotrophy (HP:0007210) | 2.12115374 |
| 72 | Furrowed tongue (HP:0000221) | 2.12054588 |
| 73 | Occipital encephalocele (HP:0002085) | 2.11842591 |
| 74 | Exotropia (HP:0000577) | 2.11819859 |
| 75 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.10856901 |
| 76 | Congenital, generalized hypertrichosis (HP:0004540) | 2.09037123 |
| 77 | Oligodactyly (hands) (HP:0001180) | 2.08336311 |
| 78 | Genital tract atresia (HP:0001827) | 2.08102947 |
| 79 | Onycholysis (HP:0001806) | 2.07987971 |
| 80 | Abnormality of binocular vision (HP:0011514) | 2.07738327 |
| 81 | Diplopia (HP:0000651) | 2.07738327 |
| 82 | Vaginal atresia (HP:0000148) | 2.07194946 |
| 83 | Thickened helices (HP:0000391) | 2.04759603 |
| 84 | Papilledema (HP:0001085) | 2.03493449 |
| 85 | Postaxial foot polydactyly (HP:0001830) | 2.03493134 |
| 86 | Ankle clonus (HP:0011448) | 2.02909683 |
| 87 | Anencephaly (HP:0002323) | 2.01673324 |
| 88 | Widely spaced teeth (HP:0000687) | 2.01485949 |
| 89 | Intention tremor (HP:0002080) | 2.01226602 |
| 90 | Lower limb asymmetry (HP:0100559) | 2.00908899 |
| 91 | Retinal dysplasia (HP:0007973) | 2.00240653 |
| 92 | Congenital stationary night blindness (HP:0007642) | 1.98489042 |
| 93 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.97723641 |
| 94 | Abnormality of the renal cortex (HP:0011035) | 1.97492366 |
| 95 | Abnormality of salivation (HP:0100755) | 1.97378184 |
| 96 | Abnormality of the axillary hair (HP:0100134) | 1.96779448 |
| 97 | Abnormality of secondary sexual hair (HP:0009888) | 1.96779448 |
| 98 | Ankyloglossia (HP:0010296) | 1.96066504 |
| 99 | Mutism (HP:0002300) | 1.95157828 |
| 100 | Pendular nystagmus (HP:0012043) | 1.94192120 |
| 101 | Sclerocornea (HP:0000647) | 1.94169312 |
| 102 | Postaxial hand polydactyly (HP:0001162) | 1.93498178 |
| 103 | Hydroureter (HP:0000072) | 1.93482584 |
| 104 | Protruding tongue (HP:0010808) | 1.92945880 |
| 105 | Chronic hepatic failure (HP:0100626) | 1.92196871 |
| 106 | Megalencephaly (HP:0001355) | 1.91564065 |
| 107 | Abnormal ciliary motility (HP:0012262) | 1.90191516 |
| 108 | Bradykinesia (HP:0002067) | 1.89716640 |
| 109 | Hypoplastic labia majora (HP:0000059) | 1.89396952 |
| 110 | Dysmetric saccades (HP:0000641) | 1.87525130 |
| 111 | Torticollis (HP:0000473) | 1.86684790 |
| 112 | Morphological abnormality of the middle ear (HP:0008609) | 1.85047472 |
| 113 | Type II lissencephaly (HP:0007260) | 1.84742581 |
| 114 | Distal lower limb amyotrophy (HP:0008944) | 1.83130852 |
| 115 | Labial hypoplasia (HP:0000066) | 1.81802055 |
| 116 | Bronchiectasis (HP:0002110) | 1.81373107 |
| 117 | Hypotrichosis (HP:0001006) | 1.81245142 |
| 118 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.80979165 |
| 119 | Conical tooth (HP:0000698) | 1.80693833 |
| 120 | Aplasia cutis congenita (HP:0001057) | 1.80368100 |
| 121 | Decreased central vision (HP:0007663) | 1.79226718 |
| 122 | Fetal akinesia sequence (HP:0001989) | 1.78907348 |
| 123 | Keratoconus (HP:0000563) | 1.78390316 |
| 124 | Increased corneal curvature (HP:0100692) | 1.78390316 |
| 125 | Congenital hepatic fibrosis (HP:0002612) | 1.78253400 |
| 126 | Male pseudohermaphroditism (HP:0000037) | 1.77455719 |
| 127 | Deeply set eye (HP:0000490) | 1.77438795 |
| 128 | Oligodactyly (HP:0012165) | 1.75765759 |
| 129 | Congenital malformation of the right heart (HP:0011723) | 1.75256865 |
| 130 | Double outlet right ventricle (HP:0001719) | 1.75256865 |
| 131 | Truncus arteriosus (HP:0001660) | 1.75243426 |
| 132 | Focal dystonia (HP:0004373) | 1.75117839 |
| 133 | Nonprogressive disorder (HP:0003680) | 1.74691213 |
| 134 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.73956733 |
| 135 | Sleep apnea (HP:0010535) | 1.71617696 |
| 136 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.71446471 |
| 137 | Preaxial hand polydactyly (HP:0001177) | 1.71024500 |
| 138 | Anophthalmia (HP:0000528) | 1.70264911 |
| 139 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.69809510 |
| 140 | Parakeratosis (HP:0001036) | 1.68480526 |
| 141 | Inappropriate behavior (HP:0000719) | 1.68306841 |
| 142 | Bronchomalacia (HP:0002780) | 1.67975045 |
| 143 | Abnormality of the labia majora (HP:0012881) | 1.67554871 |
| 144 | Poor coordination (HP:0002370) | 1.67341905 |
| 145 | Syncope (HP:0001279) | 1.66527715 |
| 146 | Gastroesophageal reflux (HP:0002020) | 1.66000440 |
| 147 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.65689327 |
| 148 | Limb dystonia (HP:0002451) | 1.65326882 |
| 149 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.65057725 |
| 150 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.65057725 |
| 151 | Amelogenesis imperfecta (HP:0000705) | 1.64444450 |
| 152 | Polyuria (HP:0000103) | 1.64423477 |
| 153 | Pointed chin (HP:0000307) | 1.64405126 |
| 154 | Milia (HP:0001056) | 1.63984169 |
| 155 | Hypoplastic female external genitalia (HP:0012815) | 1.62850137 |
| 156 | Generalized myoclonic seizures (HP:0002123) | 1.62348659 |
| 157 | Plantar hyperkeratosis (HP:0007556) | 1.61668481 |
| 158 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.60365077 |
| 159 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.60365077 |
| 160 | Esophageal atresia (HP:0002032) | 1.59503598 |
| 161 | Abnormality of the corticospinal tract (HP:0002492) | 1.58882550 |
| 162 | Acute necrotizing encephalopathy (HP:0006965) | 1.57241253 |
| 163 | Epileptiform EEG discharges (HP:0011182) | 1.56794496 |
| 164 | Specific learning disability (HP:0001328) | 1.55948065 |
| 165 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.55909647 |
| 166 | Fibular aplasia (HP:0002990) | 1.54326738 |
| 167 | Hypodontia (HP:0000668) | 1.53098587 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 6.28963388 |
| 2 | NTRK3 | 4.13820724 |
| 3 | RIPK4 | 3.71837415 |
| 4 | FRK | 3.69828400 |
| 5 | CASK | 2.98827783 |
| 6 | TNIK | 2.50560402 |
| 7 | BMPR2 | 2.45563979 |
| 8 | MAP3K12 | 2.39851054 |
| 9 | MAP3K9 | 2.24291115 |
| 10 | DAPK2 | 2.22503259 |
| 11 | MAP2K7 | 2.19572597 |
| 12 | NUAK1 | 2.06872023 |
| 13 | CDK19 | 2.05620383 |
| 14 | MAP3K4 | 2.04340571 |
| 15 | NTRK2 | 2.01074576 |
| 16 | MINK1 | 2.00934599 |
| 17 | WNK3 | 2.00130503 |
| 18 | PINK1 | 1.99378134 |
| 19 | PRPF4B | 1.65436430 |
| 20 | PLK2 | 1.60356215 |
| 21 | KSR1 | 1.57481193 |
| 22 | MAPK15 | 1.56029560 |
| 23 | FES | 1.56026552 |
| 24 | DAPK1 | 1.55378414 |
| 25 | VRK2 | 1.54981569 |
| 26 | MARK1 | 1.52909285 |
| 27 | MAP2K4 | 1.48184766 |
| 28 | KSR2 | 1.46475451 |
| 29 | CDK5 | 1.43748148 |
| 30 | PAK6 | 1.43021576 |
| 31 | SIK2 | 1.41068141 |
| 32 | INSRR | 1.39402795 |
| 33 | WNK4 | 1.39213399 |
| 34 | STK38L | 1.36119115 |
| 35 | DYRK2 | 1.36047297 |
| 36 | GRK1 | 1.35043154 |
| 37 | NTRK1 | 1.34605630 |
| 38 | CAMKK1 | 1.31664753 |
| 39 | MAP3K13 | 1.27690413 |
| 40 | TRIM28 | 1.23335259 |
| 41 | PNCK | 1.21615762 |
| 42 | RAF1 | 1.21306814 |
| 43 | OXSR1 | 1.18079433 |
| 44 | CAMK2A | 1.17585917 |
| 45 | BCR | 1.16911955 |
| 46 | TGFBR1 | 1.16628609 |
| 47 | MAPK13 | 1.15534839 |
| 48 | GRK5 | 1.13834271 |
| 49 | TNK2 | 1.10024177 |
| 50 | MUSK | 1.09856230 |
| 51 | BRSK2 | 1.08773645 |
| 52 | PTK2B | 1.07209051 |
| 53 | CAMK2B | 1.06858038 |
| 54 | MAP3K2 | 1.05635415 |
| 55 | WEE1 | 1.02704076 |
| 56 | CAMK1 | 1.02621159 |
| 57 | CAMKK2 | 1.02091400 |
| 58 | PRKCG | 1.01315332 |
| 59 | ARAF | 0.96201681 |
| 60 | STK11 | 0.95992670 |
| 61 | ACVR1B | 0.94380160 |
| 62 | PHKG2 | 0.94200836 |
| 63 | PHKG1 | 0.94200836 |
| 64 | NME1 | 0.92164423 |
| 65 | MAP4K2 | 0.89984061 |
| 66 | TLK1 | 0.88803280 |
| 67 | MARK2 | 0.87728535 |
| 68 | FER | 0.82795465 |
| 69 | MKNK2 | 0.82342392 |
| 70 | LIMK1 | 0.81520928 |
| 71 | ZAK | 0.81320376 |
| 72 | UHMK1 | 0.81271296 |
| 73 | FGR | 0.81248220 |
| 74 | MAPKAPK5 | 0.80421772 |
| 75 | EPHA2 | 0.77687670 |
| 76 | STK38 | 0.77243694 |
| 77 | PRKCH | 0.75614675 |
| 78 | PRKD3 | 0.72467493 |
| 79 | PRKCI | 0.71503376 |
| 80 | CDK18 | 0.69360734 |
| 81 | NEK6 | 0.68708972 |
| 82 | MAP3K1 | 0.67943102 |
| 83 | PRKCE | 0.67819850 |
| 84 | ERBB2 | 0.67613596 |
| 85 | CDK15 | 0.66214656 |
| 86 | MAP3K6 | 0.66000344 |
| 87 | SGK1 | 0.64957780 |
| 88 | BRSK1 | 0.63839275 |
| 89 | DYRK1A | 0.63824821 |
| 90 | TAOK1 | 0.62559299 |
| 91 | PRKD2 | 0.62259095 |
| 92 | CDK14 | 0.62128625 |
| 93 | STK39 | 0.61892967 |
| 94 | DMPK | 0.61813964 |
| 95 | CDK11A | 0.61416370 |
| 96 | PLK3 | 0.60967099 |
| 97 | VRK1 | 0.57877894 |
| 98 | TAF1 | 0.56682649 |
| 99 | ROCK2 | 0.55482726 |
| 100 | TYRO3 | 0.54432455 |
| 101 | GRK7 | 0.53954311 |
| 102 | CDK3 | 0.53610882 |
| 103 | SGK223 | 0.53466459 |
| 104 | SGK494 | 0.53466459 |
| 105 | ADRBK2 | 0.52880102 |
| 106 | SGK2 | 0.52435491 |
| 107 | CSNK1G2 | 0.52081170 |
| 108 | CAMK2D | 0.51912526 |
| 109 | PKN1 | 0.51413644 |
| 110 | PRKCZ | 0.50900925 |
| 111 | MAP3K7 | 0.50434582 |
| 112 | SIK3 | 0.50369802 |
| 113 | CSNK1A1 | 0.49830720 |
| 114 | BMPR1B | 0.48276687 |
| 115 | FGFR2 | 0.47661063 |
| 116 | PIK3CA | 0.46091038 |
| 117 | DYRK3 | 0.45891671 |
| 118 | PRKCQ | 0.44991678 |
| 119 | RET | 0.44130119 |
| 120 | MKNK1 | 0.44119906 |
| 121 | FYN | 0.44017051 |
| 122 | CSNK1E | 0.41861552 |
| 123 | EPHA3 | 0.40983451 |
| 124 | CLK1 | 0.40146972 |
| 125 | PAK3 | 0.40059361 |
| 126 | LATS2 | 0.39416909 |
| 127 | PRKCA | 0.38457451 |
| 128 | CAMK2G | 0.38257632 |
| 129 | EPHB2 | 0.38126687 |
| 130 | MST4 | 0.38020670 |
| 131 | PLK1 | 0.37961342 |
| 132 | MET | 0.37659731 |
| 133 | WNK1 | 0.37368054 |
| 134 | ADRBK1 | 0.37360359 |
| 135 | CCNB1 | 0.36852591 |
| 136 | MAPK12 | 0.36411090 |
| 137 | MST1R | 0.36244304 |
| 138 | PDPK1 | 0.35936508 |
| 139 | ERBB3 | 0.35847497 |
| 140 | PRKACA | 0.35820672 |
| 141 | MAPK10 | 0.35054631 |
| 142 | RPS6KA3 | 0.32902032 |
| 143 | PRKG1 | 0.32511337 |
| 144 | CAMK4 | 0.32050090 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.63962904 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 2.97605487 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.83589664 |
| 4 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.78358983 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.69597695 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.66363987 |
| 7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.62101252 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.54717473 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.36060145 |
| 10 | Salivary secretion_Homo sapiens_hsa04970 | 2.32627179 |
| 11 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.27911762 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.14069782 |
| 13 | Renin secretion_Homo sapiens_hsa04924 | 2.08574805 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 2.02316325 |
| 15 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.98563489 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.92991072 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.89671206 |
| 18 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.84897547 |
| 19 | Long-term depression_Homo sapiens_hsa04730 | 1.82254684 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.78785793 |
| 21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.77409868 |
| 22 | Cocaine addiction_Homo sapiens_hsa05030 | 1.68580940 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.66304973 |
| 24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.60859503 |
| 25 | Insulin secretion_Homo sapiens_hsa04911 | 1.58992428 |
| 26 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.52207421 |
| 27 | Phototransduction_Homo sapiens_hsa04744 | 1.50263073 |
| 28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.49902581 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.47440201 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.43317015 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.41912008 |
| 32 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.40002022 |
| 33 | Axon guidance_Homo sapiens_hsa04360 | 1.38659570 |
| 34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.34226342 |
| 35 | Gap junction_Homo sapiens_hsa04540 | 1.33798817 |
| 36 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.32854877 |
| 37 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.32015916 |
| 38 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.28145233 |
| 39 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.25692227 |
| 40 | Melanogenesis_Homo sapiens_hsa04916 | 1.24837987 |
| 41 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.24692949 |
| 42 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.21719395 |
| 43 | Protein export_Homo sapiens_hsa03060 | 1.17513717 |
| 44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.15977398 |
| 45 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.15847959 |
| 46 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.15375894 |
| 47 | Histidine metabolism_Homo sapiens_hsa00340 | 1.12741839 |
| 48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.12041361 |
| 49 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.09990758 |
| 50 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.09031384 |
| 51 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.07373904 |
| 52 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.06601211 |
| 53 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.05904209 |
| 54 | Glioma_Homo sapiens_hsa05214 | 1.04086744 |
| 55 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.01993291 |
| 56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.01979711 |
| 57 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.00466175 |
| 58 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.99727847 |
| 59 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.98658548 |
| 60 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.92493922 |
| 61 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.91537456 |
| 62 | Alzheimers disease_Homo sapiens_hsa05010 | 0.91124826 |
| 63 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.88441344 |
| 64 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.87613088 |
| 65 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.87606102 |
| 66 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.85561589 |
| 67 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.84215251 |
| 68 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83919071 |
| 69 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.81423356 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81281683 |
| 71 | RNA polymerase_Homo sapiens_hsa03020 | 0.80632228 |
| 72 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80162732 |
| 73 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.80129807 |
| 74 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.80078080 |
| 75 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.79680504 |
| 76 | Basal transcription factors_Homo sapiens_hsa03022 | 0.79270258 |
| 77 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.78495644 |
| 78 | Retinol metabolism_Homo sapiens_hsa00830 | 0.76935406 |
| 79 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.75642846 |
| 80 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75031803 |
| 81 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.74453100 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74266179 |
| 83 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.72979353 |
| 84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72779996 |
| 85 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.70303688 |
| 86 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.70069443 |
| 87 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.68148266 |
| 88 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.68018006 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.67937561 |
| 90 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.67832071 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66681656 |
| 92 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.66618592 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65929390 |
| 94 | Ribosome_Homo sapiens_hsa03010 | 0.64913365 |
| 95 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.63706929 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63677087 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.62766868 |
| 98 | ABC transporters_Homo sapiens_hsa02010 | 0.61803351 |
| 99 | Tight junction_Homo sapiens_hsa04530 | 0.61756541 |
| 100 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.61559856 |
| 101 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.57187695 |
| 102 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56814603 |
| 103 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.56005703 |
| 104 | Mineral absorption_Homo sapiens_hsa04978 | 0.54394611 |
| 105 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.53122248 |
| 106 | Alcoholism_Homo sapiens_hsa05034 | 0.51396621 |
| 107 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.50577370 |
| 108 | Platelet activation_Homo sapiens_hsa04611 | 0.50188649 |
| 109 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.49797604 |
| 110 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.49418189 |
| 111 | Parkinsons disease_Homo sapiens_hsa05012 | 0.48976730 |
| 112 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48087683 |
| 113 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.46963107 |
| 114 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.46958672 |
| 115 | Peroxisome_Homo sapiens_hsa04146 | 0.46587315 |
| 116 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46547596 |
| 117 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.46229667 |
| 118 | Circadian rhythm_Homo sapiens_hsa04710 | 0.45786313 |
| 119 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45064912 |
| 120 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.44312057 |
| 121 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.44272637 |
| 122 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43496480 |
| 123 | Bile secretion_Homo sapiens_hsa04976 | 0.42566703 |
| 124 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.41679452 |
| 125 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41250956 |
| 126 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41089522 |
| 127 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.40971539 |
| 128 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.40649888 |
| 129 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.36700914 |
| 130 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.36086274 |
| 131 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.35295230 |
| 132 | Endocytosis_Homo sapiens_hsa04144 | 0.33700660 |
| 133 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.32004001 |
| 134 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.31920311 |
| 135 | Melanoma_Homo sapiens_hsa05218 | 0.31035511 |
| 136 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.30794808 |
| 137 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.29990715 |
| 138 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.29813426 |
| 139 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28772567 |
| 140 | Huntingtons disease_Homo sapiens_hsa05016 | 0.28709347 |
| 141 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27999760 |
| 142 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.27311120 |
| 143 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.25884443 |

